Transplantation
Scientists at Federal University of Minas Gerais discuss research in transplantation
Published in Biotech Business Week, August 11th, 2008
"Fifty-three patients with hematological malignancies who underwent Allo-SCT from HLA-identical siblings were randomly assigned to receive glutamine-enriched parenteral nutrition -PN (GlPN, n = 27) or standard PN (PN, n 26), in isonitrogenous solutions. Deaths (D + 100 and D + 180), infections, acute GVHD, length of stay, time of neutropenia and intestinal permeability (IP) were studied," scientists in Belo Horizonte, Brazil report.
"Ages, gender, diagnosis, disease status and treatment variables were equally distributed between groups. Survival on D + 180 was increased in GlPN (74%) vs PN (46%), P = 0.03 (log-rank), as on D + 100 (P = 0.05). Most deaths occurred before...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- American Cancer Society
Hip bone density helps predict breast cancer risk - American Cancer Society
Prostate cancer patients undergoing hormone therapy may experience cognitive effects - American Society for Gastrointestinal Endoscopy
Endoscopic circumferential ablation promising for Barrett's esophagus with high-grade dysplasia - BioMed Central
Cholesterol-lowering drug boosts bone repair - BioMed Central
Frankincense provides relief to arthritis sufferers - BioMed Central
Gummy bears that fight plaque - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
